There are multiple chapters near you. Select your preferred chapter.

A new study has found that women with systemic lupus erythematosus who have problems with memory and thinking (mild cognitive impairment, or MCI) exhibit morphological brain changes.

In a new study, researchers found people with clinically active systemic lupus erythematosus (SLE) disease on standard of care can attain or achieve low disease activity (LLDAS) and meet the ...

AstraZeneca announced that the Phase III TULIP-SC trial of SAPHNELO (anifrolumab) for treatment of people with systemic lupus erythematosus met its primary endpoint. Trial results showed that ...

The Lupus Foundation of America is proud to share its 2025 Impact Report, which highlights the progress we’ve made together ...

Lupus can impact your hair in a few different ways. Many people with lupus experience hair loss or thinning hair, which can be both physically and emotionally challenging. One common cause is skin ...

The Lupus Foundation of America works to improve the quality of life for all people affected by lupus through programs of research, education, support and advocacy.

The Lupus & You: Empowerment conference is an experience that celebrates, inspires, supports, and uplifts lupus warriors, care partners, family, and friends. During this empowering day, attendees will ...

Cullinan Therapeutics has announced a licensing agreement with Genrix Bio for global rights to velinotamig, a clinical-stage BCMAxCD3 bispecific T cell engager. The agreement allows Cullinan to ...

Mesenchymal stem cells (MSCs) are unique adult stem cells with immunosuppressive properties that also may play a key role in preventing autoimmunity. In a new study, researchers identified metabolic ...

In a new study, researchers explored experiences, perceptions, and health effects of a newly developed healthy lifestyle intervention for people with systemic lupus erythematosus (SLE). This study ...